Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

124745 Press Releases
DateTitleCompany
28 Sep 15 GLG Social Impact Convenes Learning Session For City Health Works GLG,
Published by
PR Newswire
28 Sep 15 OTC Markets Group to Host Virtual Investor Conference for OTCQX Life Science Companies - October 1 OTC Markets Group,
Published by
PR Newswire
28 Sep 15 Precyse Showcases CDI Services, Technology and Education at AHIMA 2015 Precyse,
Published by
PR Newswire
28 Sep 15 Safeguard Scientifics Updates Agenda For Investor Day 2015 Safeguard Scientifics, Inc.,
Published by
PR Newswire
28 Sep 15 New Head-to-Head STIOLTO RESPIMAT Data Presented at ERS Annual Congress Boehringer Ingelheim Pharmaceuticals, Inc.,
Published by
PR Newswire
28 Sep 15 Day of Unity Press Conference in Downtown Los Angeles Safe Passage,
Published by
PR Newswire
28 Sep 15 CORRECTING and REPLACING vTv Therapeutics to Present at Ladenburg Thalmann 2015 Healthcare Conference vTv Therapeutics Inc.,
Published by
Business Wire
28 Sep 15 GenomeQuest Becomes GQ Life Sciences, Inc. GQ Life Sciences, Inc.,
Published by
Business Wire
28 Sep 15 Welch Allyn Introduces Braun ThermoScan® PRO 6000 Ear Thermometer that Offers Best-in-Class Thermometry Technology Welch Allyn, Inc.,
Published by
Business Wire
28 Sep 15 HemaCare to Sponsor Phacilitate Cell & Gene Therapy Meeting Series HemaCare Corporation,
Published by
Business Wire
28 Sep 15 Agendia Board of Directors Appoints Mark R. Straley as New Chief Executive Officer Agendia, Inc.,
Published by
Business Wire
28 Sep 15 Opexa Announces Reverse Stock Split Opexa Therapeutics, Inc.,
Published by
Business Wire
28 Sep 15 The Helsinn Group Earns Global CEO Cancer Gold Standard Accreditation The CEO Roundtable on Cancer,
Published by
Business Wire
28 Sep 15 Quintiles Recognized as Phase IV Services Leader for Third Consecutive Year Quintiles,
Published by
Business Wire
28 Sep 15 Aeglea BioTherapeutics Announces Promotion of Charles N. York to Chief Financial Officer Aeglea BioTherapeutics, Inc.,
Published by
Business Wire
28 Sep 15 Biocept Announces Participation in MultiPlan’s Networks Biocept, Inc.,
Published by
Business Wire
28 Sep 15 Ocular Therapeutix™ Submits New Drug Application to U.S. Food and Drug Administration for DEXTENZA® for the Treatment of Post-Surgical Ocular Pain Ocular Therapeutix, Inc.,
Published by
Business Wire
28 Sep 15 GNS Healthcare Strengthens Foothold in Clinical Care Management, Appoints Nationally Regarded Authorities to Strategic Advisory Board GNS Healthcare,
Published by
Business Wire
28 Sep 15 pSivida Announces NDA for Medidur™ Now Planned Using Six-Month Efficacy Data from Both Phase III Trials; FDA Concurs pSivida Corp.,
Published by
Business Wire
28 Sep 15 Veeva Network Master Data Management Becomes First Life Sciences Solution to Empower Business Users with Built-in Reporting Veeva Systems Inc.,
Published by
Business Wire
28 Sep 15 Medacta Highlights Importance of Surgeon Education for the Anterior Approach with Live Events, Webcast, and Milestone Opening of 200th Learning Center Medacta International,
Published by
Business Wire
28 Sep 15 Cynvenio Biosystems and ATGen Announce Strategic Partnership to Bring NK Vue Natural Killer Cell Test to US Market Cynvenio Biosystems, Inc.,
Published by
Business Wire
28 Sep 15 Verastem Stops Enrollment Due to Futility in the COMMAND Study of VS-6063 for the Treatment of Malignant Pleural Mesothelioma Verastem, Inc.,
Published by
Business Wire
28 Sep 15 InVivo Therapeutics’ CEO and Chairman, Mark Perrin, Featured in MedGadget Article InVivo Therapeutics Holdings Corp.,
Published by
Business Wire
28 Sep 15 Heron Therapeutics Announces Oral Presentation of Data from Completed Phase 3 MAGIC Study for SUSTOL® at the ASCO Breast Cancer Symposium Heron Therapeutics, Inc.,
Published by
Business Wire
28 Sep 15 MARIZEV® (Omarigliptin), Merck’s Once-Weekly DPP-4 Inhibitor for Type 2 Diabetes, Approved in Japan Merck,
Published by
Business Wire
28 Sep 15 BioTime’s Subsidiary Cell Cure Neurosciences Ltd. Receives FDA Fast-Track Designation for OpRegen® for the Treatment of the Dry Form of Age-Related Macular Degeneration BioTime, Inc.,
Published by
Business Wire
28 Sep 15 Ferring Pharmaceuticals acquires global rights to MILPROSATM (progesterone vaginal ring) Ferring Pharmaceuticals,
Published by
Business Wire
28 Sep 15 International Working Group on Antibody Validation Meets to Drive Toward More Effective Biomedical Research Thermo Fisher Scientific,
Published by
Business Wire
28 Sep 15 Bellicum to Present at Leerink Partners Inaugural Immuno-Oncology Roundtable Conference Bellicum Pharmaceuticals, Inc.,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.